MedPath

The Effects of Minimal Enteral Nutrition on Mesenteric Blood Flow and Oxygenation in Neonates With HIE

Not Applicable
Completed
Conditions
Hypoxic-Ischemic Encephalopathy
Interventions
Dietary Supplement: Minimal enteral nutrition
Dietary Supplement: Distilled water
Registration Number
NCT06344286
Lead Sponsor
Istanbul Training and Research Hospital
Brief Summary

The goal of this clinical trial is to evaluate the effects of minimal enteral nutrition (MEN) on mesenteric blood flow and oxygenation with Doppler USG and Near Infrared Spectroscopy (NIRS) during therapeutic hypo¬thermia (TH) in babies with hypoxic ischemic encephalopathy. The main question it aims to answer is:

1- How do the mesenteric blood flow and oxygenation get affected with MEN during TH? Participants will be either fed with MEN during TH or given placebo.

Detailed Description

Objectives: The investigators aimed to evaluate the effects of minimal enteral nutrition (MEN) on mesenteric blood flow and oxygenation with Doppler USG and Near Infrared Spectroscopy (NIRS) during therapeutic hypo¬thermia (TH) in babies with HIE.

Methods: This prospective, randomized controlled study was conducted between September 2020 to August 2022. The infants receiving MEN during hypothermia (n =30) and those who were not fed (n=30) constituted the study and control groups. Infants were monitored continuously with NIRS and mesenteric arterial blood flow velocities were measured with Doppler USG before and after feeding.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • The neonates with evidence of encephalopathy de¬fined by seizures or abnormalities on a modified Sarnat exam were enrolled. The hypoxic-ischemic injury was defined by 1. a pH of ≤ 7.0 and/or 2. base deficit >-16 mmol/L recorded in cord blood or blood gas obtained within the first hour postnatally or a pH of 7.0 - 7.15 and/or base deficit (-10-15.9) mmol/L with the presence of an acute perinatal event (cord prolapse, placental abruption, heart rate decelerations, severe fetal bradycardia). In cases where criteria 1 or 2 are met, with the presence of seizures or a diagnosis of moderate to severe encephalopathy according to the Sarnat & Sarnat classification based on neurological examination were treated with TH.
Exclusion Criteria
  • Infants with congenital malformation or hereditary metabolic diseases, infants whose enteral feeding was initiated before randomization and infants without lack of parental consent were excluded. The maternal and neonatal demographic characteristics and clinical outcomes were collected from medical records.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Infants receiving MENMinimal enteral nutritionThe babies fed with minimal enteral nutrition during TH constituted the study group
Infants receiving placeboDistilled waterThe babies who were given distilled water during TH
Primary Outcome Measures
NameTimeMethod
Cerebral and mesenteric blood flow velocities and oxygenation(From postnatal first day until postnatal 4 th day)Doppler US of SMA and MCA performed before feeding (15-30 minutes before) and 60 minutes after feeding

Cerebral and mesenteric blood flow velocities with Doppler US

Cerebral and mesenteric rSO2 values(From postnatal first day until postnatal 4 th day) Recording of NIRS data was commenced 60minutes before the initiation of TH and was continued during the procedure till 24 hours after cessation of TH

Cerebral and mesenteric rSO2 values with NIRS

Secondary Outcome Measures
NameTimeMethod
Development of NECFrom admission to NICU till postnatal 15th day or hospital discharge whichever came first,

The infants will be monitorized for NEC development

Feeding intoleranceFrom admission to NICU till postnatal 15th day or hospital discharge whichever came first,

The infants will be monitorized for feeding intolerance

Time to full enteral feedingFrom admission to NICU till postnatal 15th day or hospital discharge whichever came first,

The infants will be monitorized for the time to full enteral feeding.

Trial Locations

Locations (1)

IstanbulTRH

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath